MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Proceeds from issuance ofcommon stock$19,854K Net cash provided byfinancing activities$17,328K Effect of changes inexchange rate on cash and...$13K Canceled cashflow$2,526K Net (decrease)increase in cash and...-$39,934K Canceled cashflow$17,341K Stock-based compensationexpense$7,707K Accounts payable andaccrued expenses$3,311K Depreciation andamortization expense$2,389K Amortization of debt issuancecosts$1,362K Non-cash lease expense$1,270K Other-$1,039K Non-cash interestexpense$100K Payment of equityissuance costs$1,526K Payment of eb-5 loan$1,000K Net cash used inoperating activities-$56,964K Canceled cashflow$17,178K Net cash (used in)provided by investing...-$311K Net loss-$67,846K Prepaid expenses andother current assets$2,607K Non-cash expense(income) from...$2,462K Lease obligations-$1,227K Purchases of property andequipment$185K Payment of securitydeposits$126K
Cash Flow
source: myfinsight.com

Ocugen, Inc. (OCGN)

Ocugen, Inc. (OCGN)